U.K.'s GSK Completes Acquisition Of Sri Lanka's Stiefel
This article was originally published in PharmAsia News
Executive SummaryThe acquisition of Sri Lanka's Stiefel Laboratories by GlaxoSmithKline of the United Kingdom has been completed
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.